Skip to content
Menu

Citius Oncology, Inc. CTOR

Full chart Compare
Set alert

Price alert · CTOR

All alert types
0.50 USD -0.06 (-10.95%)

Regular-session close

0.50 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

0.502 Day range 0.5698
0.491 52-week range 1.83
YTD
-49.65%
1 year
-55.44%

5D -0.0271 (-4.82%)

0.52500.55000.5750TueWedThuFriMon0.5350
Market cap
53.25M
EPS (ttm)
-0.48
Shares out
71.30M
YTD return
-49.65%
1-year return
-55.44%
50-day average
1.13
200-day average
7.55
Volume
52.63K
Avg volume
113.40K
Open
0.5698
Previous close
0.5654
Day's range
0.502 – 0.5698
52-week range
0.491 – 1.83
Price target
3.00 (+495.8%)

Key statistics

Price / book
3.89
Free cash flow
7.11M
Return on equity
-85.28%

Fundamental scorecard

3 of 25 checks passed on CTOR’s reported financials

ValueGrowthProfitabilityHealthDividend

3of 25 checks passed

  • Value 1 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 2 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Financials — quick view

All financials
CTOR Revenue — quarterly 1.49M
CTOR Net income — quarterly -8.92M
CTOR EPS — quarterly -0.08

Upgrades / downgrades

CTOR analyst upgrades and downgrades
DateFirmActionFromTo
Nov 27, 2024Maxim Groupinit—Buy
Aug 13, 2024EF HuttonmainBuyBuy

About Citius Oncology, Inc.

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States

News

Your note

Sign in to keep a note on CTOR — it syncs with the Stock Master app.

Institution ownership

CTOR institution ownership
Holder% heldSharesValueReported
Yakira Capital Management, Inc.0.66%15,49915.19KSep 29, 2024
Virtu Financial LLC0.44%10,29110.09KSep 29, 2024
Osaic Holdings Inc0.23%5,4805.37KSep 29, 2024
UBS Group AG0.07%1,6321.60KSep 29, 2024
Bank of America Corporation0.01%160156Sep 29, 2024
Tower Research Capital LLC (TRC)0.00%4140Sep 29, 2024

Fund ownership

CTOR fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.10%2,3322.29KOct 30, 2024